Logo image of CPAY

CORPAY INC (CPAY) Stock Fundamental Analysis

NYSE:CPAY - New York Stock Exchange, Inc. - US2199481068 - Common Stock - Currency: USD

328  -12.83 (-3.76%)

After market: 328 0 (0%)

Fundamental Rating

5

Taking everything into account, CPAY scores 5 out of 10 in our fundamental rating. CPAY was compared to 101 industry peers in the Financial Services industry. While CPAY has a great profitability rating, there are some minor concerns on its financial health. CPAY is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CPAY had positive earnings in the past year.
CPAY had a positive operating cash flow in the past year.
In the past 5 years CPAY has always been profitable.
CPAY had a positive operating cash flow in each of the past 5 years.
CPAY Yearly Net Income VS EBIT VS OCF VS FCFCPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.59%, CPAY is in the better half of the industry, outperforming 79.21% of the companies in the same industry.
With an excellent Return On Equity value of 32.15%, CPAY belongs to the best of the industry, outperforming 91.09% of the companies in the same industry.
CPAY's Return On Invested Capital of 12.17% is amongst the best of the industry. CPAY outperforms 87.13% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPAY is in line with the industry average of 11.69%.
Industry RankSector Rank
ROA 5.59%
ROE 32.15%
ROIC 12.17%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
CPAY Yearly ROA, ROE, ROICCPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

CPAY has a Profit Margin of 25.25%. This is amongst the best in the industry. CPAY outperforms 82.18% of its industry peers.
In the last couple of years the Profit Margin of CPAY has declined.
With an excellent Operating Margin value of 44.18%, CPAY belongs to the best of the industry, outperforming 83.17% of the companies in the same industry.
In the last couple of years the Operating Margin of CPAY has remained more or less at the same level.
Looking at the Gross Margin, with a value of 78.13%, CPAY belongs to the top of the industry, outperforming 86.14% of the companies in the same industry.
CPAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 44.18%
PM (TTM) 25.25%
GM 78.13%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
CPAY Yearly Profit, Operating, Gross MarginsCPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

CPAY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CPAY has less shares outstanding
Compared to 5 years ago, CPAY has less shares outstanding
The debt/assets ratio for CPAY is higher compared to a year ago.
CPAY Yearly Shares OutstandingCPAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CPAY Yearly Total Debt VS Total AssetsCPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CPAY has an Altman-Z score of 2.23. This is not the best score and indicates that CPAY is in the grey zone with still only limited risk for bankruptcy at the moment.
CPAY has a Altman-Z score of 2.23. This is in the better half of the industry: CPAY outperforms 79.21% of its industry peers.
CPAY has a debt to FCF ratio of 4.53. This is a neutral value as CPAY would need 4.53 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.53, CPAY is in the better half of the industry, outperforming 68.32% of the companies in the same industry.
A Debt/Equity ratio of 2.10 is on the high side and indicates that CPAY has dependencies on debt financing.
With a Debt to Equity ratio value of 2.10, CPAY is not doing good in the industry: 65.35% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 4.53
Altman-Z 2.23
ROIC/WACC1.5
WACC8.13%
CPAY Yearly LT Debt VS Equity VS FCFCPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.00 indicates that CPAY may have some problems paying its short term obligations.
CPAY's Current ratio of 1.00 is in line compared to the rest of the industry. CPAY outperforms 48.51% of its industry peers.
CPAY has a Quick Ratio of 1.00. This is a bad value and indicates that CPAY is not financially healthy enough and could expect problems in meeting its short term obligations.
CPAY's Quick ratio of 1.00 is in line compared to the rest of the industry. CPAY outperforms 51.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CPAY Yearly Current Assets VS Current LiabilitesCPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.78% over the past year.
Measured over the past years, CPAY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.03% on average per year.
Looking at the last year, CPAY shows a small growth in Revenue. The Revenue has grown by 5.77% in the last year.
The Revenue has been growing by 8.45% on average over the past years. This is quite good.
EPS 1Y (TTM)12.78%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%10%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%7.53%

3.2 Future

CPAY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.50% yearly.
CPAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.37% yearly.
EPS Next Y12.84%
EPS Next 2Y14.61%
EPS Next 3Y15.92%
EPS Next 5Y17.5%
Revenue Next Year10.64%
Revenue Next 2Y10.54%
Revenue Next 3Y10.4%
Revenue Next 5Y9.37%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CPAY Yearly Revenue VS EstimatesCPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
CPAY Yearly EPS VS EstimatesCPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

CPAY is valuated correctly with a Price/Earnings ratio of 16.89.
CPAY's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.03, CPAY is valued a bit cheaper.
A Price/Forward Earnings ratio of 13.14 indicates a correct valuation of CPAY.
The rest of the industry has a similar Price/Forward Earnings ratio as CPAY.
CPAY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.94.
Industry RankSector Rank
PE 16.89
Fwd PE 13.14
CPAY Price Earnings VS Forward Price EarningsCPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPAY is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, CPAY is valued a bit cheaper than the industry average as 72.28% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.05
EV/EBITDA 13.79
CPAY Per share dataCPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CPAY has a very decent profitability rating, which may justify a higher PE ratio.
CPAY's earnings are expected to grow with 15.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.32
PEG (5Y)1.68
EPS Next 2Y14.61%
EPS Next 3Y15.92%

0

5. Dividend

5.1 Amount

CPAY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORPAY INC

NYSE:CPAY (5/21/2025, 8:04:00 PM)

After market: 328 0 (0%)

328

-12.83 (-3.76%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners95.47%
Inst Owner Change4.12%
Ins Owners3.33%
Ins Owner Change4.82%
Market Cap23.04B
Analysts80.77
Price Target404.12 (23.21%)
Short Float %2.29%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.61%
Min EPS beat(2)-1.78%
Max EPS beat(2)-1.45%
EPS beat(4)0
Avg EPS beat(4)-1.51%
Min EPS beat(4)-1.78%
Max EPS beat(4)-1.06%
EPS beat(8)1
Avg EPS beat(8)-1.44%
EPS beat(12)4
Avg EPS beat(12)-0.27%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-2.6%
Min Revenue beat(2)-3.5%
Max Revenue beat(2)-1.7%
Revenue beat(4)0
Avg Revenue beat(4)-2.32%
Min Revenue beat(4)-3.5%
Max Revenue beat(4)-1.7%
Revenue beat(8)1
Avg Revenue beat(8)-2.34%
Revenue beat(12)3
Avg Revenue beat(12)-1.25%
Revenue beat(16)6
Avg Revenue beat(16)-0.73%
PT rev (1m)-4.5%
PT rev (3m)-2.33%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)-0.62%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)-0.86%
Valuation
Industry RankSector Rank
PE 16.89
Fwd PE 13.14
P/S 5.8
P/FCF 13.05
P/OCF 11.87
P/B 7.38
P/tB N/A
EV/EBITDA 13.79
EPS(TTM)19.42
EY5.92%
EPS(NY)24.97
Fwd EY7.61%
FCF(TTM)25.13
FCFY7.66%
OCF(TTM)27.62
OCFY8.42%
SpS56.58
BVpS44.45
TBVpS-75.06
PEG (NY)1.32
PEG (5Y)1.68
Profitability
Industry RankSector Rank
ROA 5.59%
ROE 32.15%
ROCE 18.98%
ROIC 12.17%
ROICexc 14.27%
ROICexgc 206.41%
OM 44.18%
PM (TTM) 25.25%
GM 78.13%
FCFM 44.42%
ROA(3y)6.24%
ROA(5y)6.25%
ROE(3y)33.21%
ROE(5y)29.98%
ROIC(3y)12.51%
ROIC(5y)11.72%
ROICexc(3y)14.83%
ROICexc(5y)13.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.71%
ROCE(5y)16.98%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y1.1%
ROICexc growth 5Y0.59%
OM growth 3Y0.25%
OM growth 5Y-1.02%
PM growth 3Y-5.18%
PM growth 5Y-5.66%
GM growth 3YN/A
GM growth 5Y-4.82%
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF 4.53
Debt/EBITDA 3.11
Cap/Depr 49.9%
Cap/Sales 4.41%
Interest Coverage 3.54
Cash Conversion 92.1%
Profit Quality 175.88%
Current Ratio 1
Quick Ratio 1
Altman-Z 2.23
F-Score5
WACC8.13%
ROIC/WACC1.5
Cap/Depr(3y)47.52%
Cap/Depr(5y)42.51%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.03%
Profit Quality(3y)145.81%
Profit Quality(5y)152.95%
High Growth Momentum
Growth
EPS 1Y (TTM)12.78%
EPS 3Y12.9%
EPS 5Y10.03%
EPS Q2Q%10%
EPS Next Y12.84%
EPS Next 2Y14.61%
EPS Next 3Y15.92%
EPS Next 5Y17.5%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y11.94%
Revenue growth 5Y8.45%
Sales Q2Q%7.53%
Revenue Next Year10.64%
Revenue Next 2Y10.54%
Revenue Next 3Y10.4%
Revenue Next 5Y9.37%
EBIT growth 1Y5.97%
EBIT growth 3Y12.22%
EBIT growth 5Y7.35%
EBIT Next Year31.88%
EBIT Next 3Y17.56%
EBIT Next 5Y16.95%
FCF growth 1Y-9.34%
FCF growth 3Y17.6%
FCF growth 5Y10.19%
OCF growth 1Y-7.64%
OCF growth 3Y17.47%
OCF growth 5Y10.8%